Announcing The Lancet Global Health Commission on Global Eye Health by Burton, Matthew J. et al.
Comment
www.thelancet.com/lancetgh   Published online October 9, 2019   https://doi.org/10.1016/S2214-109X(19)30450-4 1
Announcing The Lancet Global Health Commission on Global 
Eye Health
Eye health has profound and widespread implications 
for many aspects of life, health, sustainable devel­
opment, and the economy. Yet many populations do 
not have access to good­quality, affordable eye care.
Worldwide there are more than 250 million people 
living with vision impairment, among whom 36 million 
are blind.1 In addition, over a billion people have near­
vision impairment, simply because they do not have a 
pair of reading spectacles. Eye conditions and the vision 
impairment they cause affect all stages of life, with 
increasing burden with age. Over the next 30 years, 
ageing and growth of the global population will lead 
to a tripling of people affected, with 700 million vision 
impaired and 115 million of these blind.1 Critically, 80% of 
this sight loss is preventable or treatable, and 90% occurs 
in low­income and middle­income countries (LMICs). 
Sight loss has substantial economic implications for 
affected individuals, families, and communities, with 
global estimates of annual costs exceeding US$ 3 trillion.2
Good vision facilitates many activities of daily life and 
improves education and employment opportunities. 
Available good quality evidence shows that improved 
eye health offers the potential to advance progress 
towards the Sustainable Development Goals (SDGs), 
including those pertaining to poverty, hunger, good 
health and wellbeing, education, gender equality, and 
decent work.3–5
Sight loss has many causes that require a range of 
promotive, preventive, curative, and rehabilitative inter­
ventions. Cataract, refractive error, age­related macular 
degeneration (AMD), glaucoma, corneal opacity, and 
diabetic retinopathy are responsible for the majority 
of global vision impairment.6 While interventions 
are available for these, there is a pressing need for 
research to improve detection, therapeutic efficacy, and 
implementation. Moreover, many of these interventions 
remain out of reach for millions living in underserved 
regions in LMICs as well as disadvantaged populations in 
high­income countries.
In the quest to achieve universal eye health, a critical 
obstacle is the major shortage and maldistribution 
of appropriately trained personnel, particularly in 
Africa and rural areas within LMICs in other regions. 
Addressing this shortfall requires novel and scalable, 
evidence­based approaches to human capacity building 
and implementation of effective strategies to improve 
access to care. Mobile health, artificial intelligence, 
and distance­learning have already demonstrated 
the potential for existing cadres of health workers to 
deliver more, high­quality and equitably­distributed 
care.7
Strategic partnerships with natural allies in areas 
such as non­communicable diseases, education, and 
paediatrics, must be forged. Furthermore, the eye 
health sector can better utilise health promotion 
and prevention strategies to lessen the impact of eye 
disease and reduce inequality. Globally women are 
more likely than men to be vision impaired, and this 
pervasive gender inequality in eye health must be 
addressed.6 
Our challenge is to develop and deliver 
comprehensive eye health services that cover the full 
range of health promotion, prevention, detection, 
management, and rehabilitation strategies, that are 
integrated into the general health system, people­
centred, and aligned with the SDGs. Lessons from 
recent decades give hope that this challenge can be 
met. In 1999, VISION 2020, a global programme to 
address avoidable sight loss, was launched by WHO 
and the International Agency for the Prevention of 
Blindness. Although the total number of people with 
impaired vision has risen since the millennium due to 
population growth and ageing, the age­standardised 
prevalence has declined by 16%, indicating programme 
impact.8
However, at the same time there are new threats to 
global eye health, including the explosion of diabetic 
retinopathy worldwide, high myopia in Asia, and 
AMD in older people. With the projected increased 
magnitude of vision loss over the coming decades, 
urgent action is needed to achieve the substantial 
reductions in avoidable vision impairment called for 
by WHO in the World Report on Vision,9 published this 
week.
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Health, whose report will appear in this journal on World 
Sight Day 2020. This Commission will:
• Analyse the current state of eye health in low­
income, middle­income, and high­income countries
• Examine the implications of projected growth of 
global burden of eye disease and sight loss
• Provide updated estimates of the economic cost of 
vision impairment and the return on investment 
from efforts to improve eye health
• Identify knowledge gaps impeding design and 
delivery of better, more equitable services, through a 
global “Grand Challenges” exercise
• Make the political, social, and economic case for 
action to achieve real and lasting reductions in the 
global burden of avoidable vision loss
• Review established and novel, evidence­based 
strategies to deliver high­quality eye health 
services. These services should integrate well with 
existing health­care systems, should be mindful of 
environmental sustainability, and deliver services for 
all so that no one is left behind
The year 2020 marks the culmination of VISION 
2020. This is a pivotal time for the global eye 
health community and its partners in health care, 
government, and other sectors to consider both the 
successes and challenges experienced through our 
shared efforts in recent decades. The Commission 
will weave together lessons learned with growing 
evidence for the life­transforming impact of eye 
care and a thorough understanding of research and 
technological developments in this field. The resulting 
report will be informed by broad consultation with 
experts within and outside of eye care. Alongside 
the World Report on Vision,9 the Commission will 
help to inform governments, communities, and 
other stakeholders about the route beyond 2020 
to further the SDGs, including universal health 
coverage, by promoting a world without avoidable 
vision loss.
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